JANSSEN DARATUMUMAB daratumumab 100 mg/5 mL concentrated solution for infusion vial Cancelled under Section 30(1)(c) of the Act
Product name
JANSSEN DARATUMUMAB daratumumab 100 mg/5 mL concentrated solution for infusion vial
Sponsor
ARTG
281844
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act